Pharmacogenetics of Complement Factor H (Y402H) and Treatment of Exudative Age-Related Macular Degeneration With Ranibizumab

British Journal of Ophthalmology - United Kingdom
doi 10.1136/bjo.2008.150995
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Inflammation, Complement Factor H, and Age-Related Macular Degeneration

Ophthalmology
Ophthalmology
2008English

Complement Factor H Polymorphism in Age-Related Macular Degeneration

American Journal of Ophthalmology
Ophthalmology
2005English

Molecular Mechanisms of Macular Degeneration Associated With the Complement Factor H Y402H Mutation

Biophysical Journal
Biophysics
2019English

Association of Complement Factor H and LOC387715 Genotypes With Response of Exudative Age-Related Macular Degeneration to Photodynamic Therapy

Eye
MedicineArtsSensory SystemsOphthalmologyHumanities
2008English

Results of Switchback From Ranibizumab to Aflibercept in Patients With Exudative Age-Related Macular Degeneration

Clinical Ophthalmology
Ophthalmology
2019English

Comparison of the Effect Between Pegaptanib and Ranibizumab on Exudative Age-Related Macular Degeneration With Small Lesion Size

Clinical Ophthalmology
Ophthalmology
2012English

Phenotypic Characterization of Complement Factor H R1210C Rare Genetic Variant in Age-Related Macular Degeneration

JAMA Ophthalmology
Ophthalmology
2015English

Complement Factor H and Age-Related Macular Degeneration: The Role of Glycosaminoglycan Recognition in Disease Pathology

Biochemical Society Transactions
Biochemistry
2010English

Rare Variants in the Functional Domains of Complement Factor H Are Associated With Age-Related Macular Degeneration

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy